2 In 2024, the approved commercial versions of semaglutide are Ozempic 3-4 , Rybelsus 3,5 , and Wegovy injection 3,6 , developed by Novo Nordisk
You may feel stronger effects of the alcohol or experience blood sugar changes (15)
Pre-existing gastrointestinal conditions, particularly gastroparesis or irritable bowel syndrome, significantly affect tolerability and may necessitate slower escalation or lower maintenance doses
Ro pivoted to FDA-approved branded medications only, including the Wegovy pill (FDA-approved December 2025, launched January 2026)
According to results of a retrospective, real-world cohort study, glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be beneficial when used as adjunct therapy in the management of Crohns disease (CD) for patients who also have a diagnosis of overweight or obesity